PW Medtech reports HK$407,100 share buyback for cancellation

PW Medtech Group Limited, listed on the Exchange, reported a share repurchase on November 7, 2025. The company repurchased 295,000 ordinary shares on the Exchange at a highest and lowest price of HK$1.38 per share, totaling an aggregate price paid of HK$407,100. These shares are intended for cancellation.

This recent repurchase brings the total number of shares repurchased for cancellation but not yet cancelled to 295,000 as of November 7, 2025. The company's opening balance of issued shares (excluding treasury shares) as of October 31, 2025, stood at 1,473,589,098, remaining unchanged after this event.

The company's board had approved a repurchase mandate on June 10, 2025, authorizing the repurchase of up to 148,673,509 shares. As of November 7, 2025, PW Medtech has repurchased 15,147,000 shares, representing 1.0188% of the issued shares (excluding treasury shares) as at the date of the resolution. A moratorium period for new share issues or treasury share transfers following these repurchases extends until December 7, 2025.